Institutional Ownership Vor Biopharma Inc. (VOR)
This table provides information about the institutional ownership of Vor Biopharma Inc. (VOR). We have compiled data on the 73 institutions that hold shares in the stock, with a total of 47.9 Million shares, which have been reported (via 13F filing form) to have a value of $30.7 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2024 Q2 2024 |
22,748,880
shares
|
$14.6 Million
0.34% of portfolio
|
Q2 2024
New holding
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2024 Q2 2024 |
6,457,293
shares
|
$4.13 Million
0.26% of portfolio
|
Q4 2023
Reduced 0.06%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
6,361,723
shares
|
$4.07 Million
2.98% of portfolio
|
Q4 2021
Reduced 4.94%
|
|
Laurion Capital Management LP
New York, NY |
Aug 14, 2024 Q2 2024 |
2,525,449
shares
|
$1.62 Million
0.03% of portfolio
|
Q2 2024
Reduced 20.66%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
1,954,285
shares
|
$1.25 Million
0.0% of portfolio
|
Q2 2024
Added 7.8%
|
|
Johnson & Johnson
New Brunswick, NJ |
Aug 09, 2024 Q2 2024 |
1,074,658
shares
|
$687,781
0.37% of portfolio
|
Q3 2021
New holding
|
|
Sarissa Capital Management LP
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
618,000
shares
|
$395,520
0.1% of portfolio
|
Q2 2022
Reduced 12.59%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
497,696
shares
|
$318,525
0.0% of portfolio
|
Q2 2024
Reduced 77.86%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
495,300
shares
|
$316,992
0.0% of portfolio
|
Q2 2024
Added 48.0%
|
|
Mai Capital Management
|
Aug 12, 2024 Q2 2024 |
470,068
shares
|
$300,843
0.0% of portfolio
|
Q2 2024
Added 28.48%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
424,832
shares
|
$271,892
0.0% of portfolio
|
Q2 2024
Reduced 49.5%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
389,638
shares
|
$249,368
0.0% of portfolio
|
Q2 2024
Added 146.0%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
380,743
shares
|
$243,675
0.0% of portfolio
|
Q2 2024
Reduced 4.42%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 13, 2024 Q2 2024 |
375,342
shares
|
$240,218
0.0% of portfolio
|
Q2 2024
Added 302.85%
|
|
Oup Management Co., LLC
|
Nov 09, 2023 Q3 2023 |
374,714
shares
|
$239,816
1.79% of portfolio
|
Q4 2021
New holding
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Aug 13, 2024 Q2 2024 |
346,087
shares
|
$221,495
0.0% of portfolio
|
Q1 2023
Added 15.55%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 15, 2024 Q2 2024 |
247,167
shares
|
$158,186
0.0% of portfolio
|
Q2 2024
Added 829.86%
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
222,501
shares
|
$142,400
0.0% of portfolio
|
Q2 2024
Added 1041.5%
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
169,300
shares
|
$108,352
0.0% of portfolio
|
Q1 2024
Reduced 26.37%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2024 Q2 2024 |
165,900
shares
|
$106,176
0.0% of portfolio
|
Q2 2024
Added 25.02%
|
|
Y Intercept (Hong Kong) LTD
|
Aug 14, 2024 Q2 2024 |
132,298
shares
|
$84,670
0.01% of portfolio
|
Q2 2024
New holding
|
|
Exchange Traded Concepts, LLC
|
Aug 13, 2024 Q2 2024 |
117,788
shares
|
$75,384
0.0% of portfolio
|
Q2 2024
Reduced 23.73%
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
115,934
shares
|
$74,197
0.0% of portfolio
|
Q2 2024
Reduced 82.37%
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2024 Q2 2024 |
95,367
shares
|
$61,034
0.0% of portfolio
|
Q2 2024
New holding
|
|
Trustees Of Columbia University In The City Of New York
New York, NY |
Feb 13, 2024 Q4 2023 |
91,910
shares
|
$58,822
0.44% of portfolio
|
Q3 2021
Reduced 50.0%
|